Old Web
English
Sign In
Acemap
>
authorDetail
>
David Abernethy
David Abernethy
Wellington Management Company
Biology
Immunology
Population
Internal medicine
Polymyositis
4
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The latitude gradient for multiple sclerosis prevalence is established in the early lifecourse.
2021
Brain
Clive E. Sabel
John F. Pearson
Deborah Mason
Ernest Willoughby
David Abernethy
Bruce V. Taylor
Show All
Source
Cite
Save
Citations (1)
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial
2020
Anne Camille La Flamme
David Abernethy
Dalice Sim
Liz Goode
Michelle Lockhart
David Bourke
Imogen Milner
Toni-Marie Garrill
Purwa Joshi
Eloise Watson
Duncan Smyth
Sean Lance
Bronwen Connor
Show All
Source
Cite
Save
Citations (3)
Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls
2017
Immunology and Cell Biology
Delgertsetseg Chuluundorj
Scott A. Harding
David Abernethy
Anne Camille La Flamme
Show All
Source
Cite
Save
Citations (13)
Trichinella pseudospiralis in humans : description of a case and its treatment
1994
Transactions of The Royal Society of Tropical Medicine and Hygiene
John R.H. Andrews
Ruth Ainsworth
David Abernethy
Show All
Source
Cite
Save
Citations (27)
1